Surgical 3D Printing Market Size, Share, By Component (Equipment, Materials, Services & Software), By Application (External Wearable Devices, Tissue Engineering, Implants, and Clinical Study Devices), By Technology (Electronic Beam Melting (EBM), Laser Beam Melting, Photopolymerization, Droplet Deposition (DD), and Others), Industry Analysis, Growth, Trends, and Forecast, 2026-2033
Report ID
MSI-2298
Published
February 3, 2026
Pages
312 Pages
Format
Report Details
Comprehensive Market Analysis And Insights
Market Definition
3D Printing medical system is based on a patient's imaging data.Medical devices that are printed at the point of care include patient-matched anatomical models, prosthetics, and surgical guides, which are used to guide surgeons during an operation.
Global Surgical 3D Printing market size is valued at USD 3369.9 million in 2025 and projected to grow at a CAGR of 17.8% during the forecast period, reaching USD 12496.3 million by 2033
Market Dynamics
Technological advancements in surgical 3D printing is a key driving factor of the market. Companies are focusing on developing advanced and innovative 3D printing system for surgery. For instance, Anatomics has designed and developed world-first 3D printed titanium sternum and rib implant for the patient in suffering from cancer in the chest.The customizable implant can be adjusted to fit into the affected area and secured in place with screws. The people suffering from sarcoma use 3D printed titanium sternum and rib implant.Sarcoma cancer occurs in bone, cartilage, fat, muscle, vascular, or hematopoietic tissues. Further, TRUMPF has offered TRUMPF 3D printer to produce craniomaxillofacial implants. The surgeon use TRUMPF 3D printer to cut the craniomaxillofacial implant from perforated titanium plate during the procedure and then shape it to the size. Additionally, Renovis Surgical has introduced3D-printed Posterior Lumbar Interbody Fusion Systems. The company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market posterior lumbar Tesera porous titanium interbody fusion systems. However, the high cost associated with surgical 3D printing might hamper market growth. The cost of the standard 3D printing material varies by process from approximately $25 per kilogram for FDM filaments, to $50-60 per kilogram of SLA resin. Larger parts of the 3D printed system need more material and will take longer to print, which leads to increasing cost. Moreover, Rising investment and funding for surgical 3D printing would provide lucrative opportunities for the market in the coming years.
Market Segmentation
The global surgical 3D printing market is mainly classified based on technology, component, and application. Technology is further segmented into Electronic Beam Melting (EBM), Laser Beam Melting, Photopolymerization, Droplet Deposition (DD), and Others. By component, the market is divided into Equipment, Materials, and Services & Software. By application, the market is further divided into External Wearable Devices, Tissue Engineering, Implants, and Clinical Study Devices.
Equipment segment is valued at USD 688.8 million in 2026 and is projected to reach USD 2249.3 million by 2033, at a CAGR of 18.4% during the forecast period.
Based on technology, Photopolymerization was dominating the global surgical 3D printing market in 2019, owing to the widespread application of photopolymerization technology across various medical applications such as for manufacturing surgical guides including orthopedic, dental, and CMF guides; prosthetics and implants; porous scaffolds; and dental restorations.
External Wearable Devices segment is projected to reach USD 7210.4 million by 2033, at a CAGR of 16.4% during the forecast period.
The partnership between companies to extend the range of applications for surgical 3D printing system is driving the market demand. For instance, Structo, a dental 3D printing solutions provider and the manufacturer has partnered with German 3D printing materials company, pro3dure. The partnership will help Velox users gain access to pro3dure’s range of dental 3D printing materials.Velox is an all-in-one desktop 3D printer with autonomous post-processing aimed at spearheading the adoption of 3D printing in dental practices.pro3dure manufactures various photopolymer materials for dental, audiology and medical applications.
Regional Analysis
Based on geography, the global surgical 3D printing market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is further divided in the U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is segmented into India, China, Japan, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa.
North America was dominating the global surgical 3D printing market in 2019, due to the commercialization of regulatory approved surgical 3D printing system, rising investment and expanding the development facility for the surgical 3D printing system, and strategic collaboration between companies to develop surgical 3D printing system. For instance, GE Healthcare has collaborated with Formlabs, a Massachusetts-based manufacturer of advanced 3D-printers that can help clinicians quickly print anatomical models at the point of care. These models visualize patient anatomy and disease for improved communication within the medical team, case-based teaching models and enhanced patient education.
Competitive landscape
Key players operating in the surgical 3D printing industry include 3D Systems Corporation, Stratasys Ltd., Envisiontec GmbH, Renishaw plc, Materialise NV, 3T Additive Manufacturing Ltd., Arcam AB, EOS GmbH Electro Optical Systems, Prodways Group, and Concept Laser GmbH.
The companies are commercializing technologically advanced surgical 3D printing system, the partnership between companies to develop 3D printing system for the medical industry, rising investment, facility expansion to manufacture 3D printing system for medical applications, and regulatory approval of surgical 3D printing system are some of the strategies adopted by the major companies. For instance, Materialise NV, a leading company in 3D technology solutions has received CE Marking Certification for its personalized orthopaedic and cranio-maxillofacial (CMF) solutions, which includes 3D-printed anatomical models and patient-matched surgical guides and implants. Materialise is one of the first company to acquire CE certification for personalized, 3D-printed medical device portfolio. The CE approval will make the technology more accessible for surgeons.
North America (By Component, Application, Technology, and Country)
United States
Canada
Mexico
Europe (By Component, Application, Technology, and Country)
Germany
France
UK
Italy
Spain
Russia
Rest of the Europe
Asia Pacific (By Component, Application, Technology, and Country)
China
Japan
India
South Korea
Australia
Southeast Asia
Rest of Asia Pacific
South America (By Component, Application, Technology, and Country)
Brazil
Argentina
Rest of South America
Middle East and Africa (By Component, Application, Technology, and Country)
Saudi Arabia
UAE
South Africa
Rest of Middle East and Africa
What Report Provides
Key Company Market Share, Revenue, and Position/Ranking
Key Market Leaders
Full In-Depth Analysis of the Parent Industry
Industry Statistics
Important Changes in Market and Its Dynamics
Segmentation Details of the Market
Historical, On-Going, and Projected Market Analysis
Assessment of Niche Industry Developments
Market Share Analysis
Key Strategies of Major Players
Company Profiles of Key Players
Unique Selling Prepositions of Leading Market Players
Emerging Segments and Regional Growth Potential
Key Strategic Recommendations
Competitive Benchmarking
Import Export Trade Statistics
End of Report Overview
Frequently Asked Questions
Find answers to common questions about this report
Top players operating in the Surgical 3D Printing industry includes 3D Systems Corporation, Stratasys Ltd., Envisiontec GmbH, Renishaw plc, EOS GmbH Electro Optical Systems, Materialise NV, 3T Additive Manufacturing Ltd., Arcam AB, Prodways Group, and Concept Laser GmbH
The Surgical 3D Printing market is projected to grow at a CAGR of 17.8% during the forecast period from 2026 to 2033.
According to Metastat Insights analysis, the North America Surgical 3D Printing market size is estimated to reach USD 4623.6 million by 2033.
The Metastat Insights study reveals that the Surgical 3D Printing market size was valued at USD 3369.9 million in 2025.
Skin Cancer Diagnostics Market Size, Share, Trends, 2033
Skin Cancer Diagnostics market size is valued at USD 9.92 billion in 2025 and projected to reach USD 16.03 billion by 2033, growing at a CAGR of 6.2%.
Skin Cancer Diagnostics market, Skin Cancer Diagnostics Market Size, Skin Cancer Diagnostics Market Share, Skin Cancer Diagnostics Market Analysis, Skin Cancer Diagnostics Market Growth, Skin Cancer Diagnostics Market Trends, Skin Cancer Diagnostics Market Research Report, Skin Cancer Diagnostics Market Forecast, Skin Cancer Diagnostics, Skin Cancer Diagnostics Market Research, Skin Cancer Diagnostics Industry, Skin Cancer Diagnostics Industry Report, Skin Cancer Diagnostics Market Data, Skin Cancer Diagnostics Statistics, Skin Cancer Diagnostics Market Statistics, Skin Cancer Diagnostics Industry Trends, Skin Cancer Diagnostics Market Report, Skin Cancer Diagnostics Market Trends, Skin Cancer Diagnostics Market News, Skin Cancer Diagnostics Forecasts, Skin Cancer Diagnostics Market Intelligence Report, Skin Cancer Diagnostics market 2033, Skin Cancer Diagnostics market outlook, Skin Cancer Diagnostics market segmentation, Skin Cancer Diagnostics market drivers, Skin Cancer Diagnostics market restraints, Skin Cancer Diagnostics market opportunities, Skin Cancer Diagnostics market CAGR, Skin Cancer Diagnostics suppliers, Skin Cancer Diagnostics manufacturers, Skin Cancer Diagnostics market by region, North America Skin Cancer Diagnostics market, Asia Pacific Skin Cancer Diagnostics market, Europe Skin Cancer Diagnostics market, Skin Cancer Diagnostics market competitive landscape, Skin Cancer Diagnostics market key players, Melanoma Detection and Monitoring market, Non-Melanoma Skin Cancer Detection market, Basal Cell Carcinoma Diagnosis market, Squamous Cell Carcinoma Diagnosis market, Skin Lesion Monitoring and Surveillance market, Dermatology Clinics Skin Cancer Diagnostics, Hospitals and Specialty Cancer Centers Skin Cancer Diagnostics.
Bone Graft Substitutes Market Size, Share, Trends, 2033
Bone Graft Substitutes market size is valued at USD 1,004.1 million in 2025 and is projected to reach USD 5,275.6 million by 2033, growing at a CAGR of 6.0%.
Bone Graft Substitutes market, Bone Graft Substitutes Market Size, Bone Graft Substitutes Market Share, Bone Graft Substitutes Market Analysis, Bone Graft Substitutes Market Growth, Bone Graft Substitutes Market Trends, Bone Graft Substitutes Market Research Report, Bone Graft Substitutes Market Forecast, Bone Graft Substitutes, Bone Graft Substitutes Market Research, Bone Graft Substitutes Industry, Bone Graft Substitutes Industry Report, Bone Graft Substitutes Market Data, Bone Graft Substitutes Statistics, Bone Graft Substitutes Market Statistics, Bone Graft Substitutes Industry Trends, Bone Graft Substitutes Market Report, Bone Graft Substitutes Market Trends, Bone Graft Substitutes Market News, Bone Graft Substitutes Forecasts, Bone Graft Substitutes Market Intelligence Report, Bone Graft Substitutes Market 2033, Bone Graft Substitutes Market Outlook, Bone Graft Substitutes Market Segmentation, Bone Graft Substitutes Market Drivers, Bone Graft Substitutes Market Restraints, Bone Graft Substitutes Market Opportunities, Bone Graft Substitutes Market CAGR, Bone Graft Substitutes Suppliers, Bone Graft Substitutes Manufacturers, Bone Graft Substitutes Market by Region, North America Bone Graft Substitutes Market, Asia Pacific Bone Graft Substitutes Market, Europe Bone Graft Substitutes Market, Bone Graft Substitutes Market Competitive Landscape, Bone Graft Substitutes Market Key Players, Mineralized Bone Allografts Market, Demineralized Bone Matrix Market, Cellular Bone Matrices Market, Synthetic Bone Graft Substitutes Market, Bone Morphogenetic Protein-Based Grafts Market, Spinal Fusion Bone Graft Substitutes, Trauma and Long-Bone Repair Bone Graft Substitutes, Joint Reconstruction Bone Graft Substitutes, Dental Bone Grafting Market.
Advanced Oral Drug Delivery Market Size, Share, Trends, 2033
Advanced Oral Drug Delivery market is valued at USD 42.2 billion in 2025 and projected to reach USD 75.9 billion by 2033, growing at a CAGR of 7.6%.
Advanced Oral Drug Delivery market, Advanced Oral Drug Delivery Market Size, Advanced Oral Drug Delivery Market Share, Advanced Oral Drug Delivery Market Analysis, Advanced Oral Drug Delivery Market Growth, Advanced Oral Drug Delivery Market Trends, Advanced Oral Drug Delivery Market Research Report, Advanced Oral Drug Delivery Market Forecast, Advanced Oral Drug Delivery, Advanced Oral Drug Delivery Market Research, Advanced Oral Drug Delivery Industry, Advanced Oral Drug Delivery Industry Report, Advanced Oral Drug Delivery Market Data, Advanced Oral Drug Delivery Statistics, Advanced Oral Drug Delivery Market Statistics, Advanced Oral Drug Delivery Industry Trends, Advanced Oral Drug Delivery Market Report, Advanced Oral Drug Delivery Market Trends, Advanced Oral Drug Delivery Market News, Advanced Oral Drug Delivery Forecasts, Advanced Oral Drug Delivery Market Intelligence Report, Advanced Oral Drug Delivery Market 2033, Advanced Oral Drug Delivery Market Outlook, Advanced Oral Drug Delivery Market Segmentation, Advanced Oral Drug Delivery Market Drivers, Advanced Oral Drug Delivery Market Restraints, Advanced Oral Drug Delivery Market Opportunities, Advanced Oral Drug Delivery Market CAGR, Advanced Oral Drug Delivery Suppliers, Advanced Oral Drug Delivery Manufacturers, Advanced Oral Drug Delivery Market by Region, North America Advanced Oral Drug Delivery Market, Asia Pacific Advanced Oral Drug Delivery Market, Europe Advanced Oral Drug Delivery Market, Advanced Oral Drug Delivery Market Competitive Landscape, Advanced Oral Drug Delivery Market Key Players, Amorphous Solid Dispersions Advanced Oral Drug Delivery, Lipid-Based Drug Delivery Systems Advanced Oral Drug Delivery, Nanocrystal and Nanoparticle Engineering Advanced Oral Drug Delivery, Porous-Carrier and Adsorption-Based Systems Advanced Oral Drug Delivery, Tablets Advanced Oral Drug Delivery, Capsules and Softgels Advanced Oral Drug Delivery, Immediate Release Advanced Oral Drug Delivery, Extended and Sustained Release Advanced Oral Drug Delivery, Delayed and Enteric Release Advanced Oral Drug Delivery, Targeted and Site-Specific Release Advanced Oral Drug Delivery.
Global Anaerobic Incubators market size is valued at USD 177.5 million in 2025 and is projected to reach USD 323.6 million in 2033, at a CAGR of 7.8% from 2026 to 2033